Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

6.3%

1 terminated/withdrawn out of 16 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

13%

2 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 1
7(53.8%)
Phase 2
4(30.8%)
Phase 3
2(15.4%)
13Total
Phase 1(7)
Phase 2(4)
Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (16)

Showing 16 of 16 trials
NCT05252429Phase 2Active Not Recruiting

Docetaxel/Pembrolizumab in Head and Neck Squamous Cell Carcinoma

Role: lead

NCT05863234Phase 1Recruiting

Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia

Role: collaborator

NCT03461497Active Not Recruiting

Development of a Patient-Reported Outcome Measure to Assess Recovery After Abdominal Surgery

Role: collaborator

NCT06752720Phase 2Recruiting

Intracerebral Autologous Stem Cell Therapy for Chronic Stroke Patients

Role: lead

NCT06361433Phase 1Recruiting

Intracerebral Transplantation of Autologous MSC Combined With Scaffold Product for Chronic Intracerebral Hemorrhage

Role: lead

NCT02528006Phase 2Completed

Treatment for Adductor Spasmodic Dysphonia by Type 2 Thyroplasty Using Titanium Bridges

Role: collaborator

NCT01798654Completed

EUS-FNA for Patients With Antithrombotic Agents

Role: collaborator

NCT00209690Phase 1Completed

Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer.

Role: collaborator

NCT00209716Phase 1Completed

Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer.

Role: collaborator

NCT00209729Phase 1Suspended

Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer.

Role: collaborator

NCT00209742Phase 3Unknown

Randomized Phase III Adjuvant Study for Stage III Colorectal Cancer

Role: collaborator

NCT00209612Phase 1Withdrawn

Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC.

Role: collaborator

NCT00209677Phase 1Suspended

Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

Role: collaborator

NCT00209651Phase 2Unknown

Phase II Study of Oral S-1 Plus Irinotecan (IRIS) in Patients With Advanced Colorectal Cancer

Role: collaborator

NCT00316745Phase 3Suspended

IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer

Role: collaborator

NCT00406835Completed

Prospective Randomized Trial Between WBRT Plus SRS Versus SRS Alone for 1-4 Brain Metastases

Role: lead

All 16 trials loaded